Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Botulinum Toxin Injection for the Management of BPH [Phase 2]
Phase 2 clinical trial update on botulinum toxin injection for managing benign prostatic hyperplasia has completed with results posted.
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications [Phase 4]
Phase 4 clinical trial update on the Clasic Laryngeal Mask Airway (C-LMA) and I-gel focusing on regurgitation and related complications; cur…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate [Phase 4]
This Phase 4 clinical trial update examined dutasteride in men with benign prostatic hyperplasia, focusing on its effects on HIF-1alpha and …
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia [Phase 4]
A Phase 4 clinical trial evaluating non-steroidal anti-inflammatory drugs for benign prostatic hyperplasia has been withdrawn.
-
FDA approval · 2013-05-30FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) submitted by Advanz Pharma (US) Corp.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy. [Phase 4]
A Phase 4 clinical trial update evaluating low-dose bupivacaine spinal anesthesia for transurethral prostatectomy in men with Benign Prostat…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: A Study in Benign Prostatic Hyperplasia [Phase 3]
Phase 3 study in Benign Prostatic Hyperplasia completed with results posted May 20, 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management [NA]
This is a completed clinical trial comparing TRP versus Photo Selective Vaporization for obstructive benign prostatic hyperplasia management…
-
FDA approval · 2013-04-30FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Avodart (dutasteride) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2013-04-30FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of tamsulosin hydrochloride from Aurobindo Pharma Limited under an original ANDA. The product is used to trea…
-
FDA approval · 2013-04-26FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for finasteride submitted by Accord Healthcare, Inc.
-
FDA label_change · 2013-04-26FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for DOXAZOSIN (doxazosin mesylate) by Teva Pharmaceuticals USA, Inc., indicating an approved modific…
-
FDA approval · 2013-04-25FDA Approved: JALYN — Supplemental Application (Waylis Therapeutics)
The FDA approved a supplemental application for Jalyn (dutasteride and tamsulosin hydrochloride) from Waylis Therapeutics.
-
FDA approval · 2013-04-25FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for finasteride from Teva Pharmaceuticals USA, Inc. The approval updates the labeling for the generi…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination [Phase 1]
Phase 1 pharmacokinetic comparison of GL2701 in combination with finasteride and tamsulosin for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly [NA]
A completed clinical trial evaluating intrathecal dexmedetomidine added to low-dose bupivacaine for spinal anesthesia in elderly patients un…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms [Phase 3]
Phase 3 study assessing tadalafil with finasteride for men with benign prostatic hyperplasia and urinary symptoms; results were posted in 20…
-
FDA approval · 2013-02-26FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited, confirming approval of a generic version of finas…
-
FDA approval · 2013-02-22FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental ANDA for finasteride, a routine supplemental approval for a generic product.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia [Phase 4]
Phase 4 clinical trial evaluating solifenacin as add-on therapy for overactive bladder symptoms in men treated for benign prostatic hyperpla…
-
FDA approval · 2013-01-16FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
FDA label_change · 2012-12-29FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration [Phase 4]
A Phase 4 trial reports that adding lidocaine to levobupivacaine reduces the duration of intrathecal anesthesia in patients with benign pros…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia [Phase 2]
A Phase 2 study evaluating botulinum toxin type A for lower urinary symptoms due to benign prostatic hyperplasia has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 2]
A Phase 2 trial evaluating light-activated talaporfin disodium for lower urinary tract symptoms due to benign prostatic hyperplasia has comp…